<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00540215</url>
  </required_header>
  <id_info>
    <org_study_id>H-D-2007-0050</org_study_id>
    <nct_id>NCT00540215</nct_id>
  </id_info>
  <brief_title>GLP-2 (Glucagonlike Peptide-2) and Blood Flow</brief_title>
  <official_title>The Role of GLP-2 in Univercal Changes in Blood Flow in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is the study aim to investigate the effect of glp-2 on blood flow in humans. we wish to
      study eventual changes in renal blood flow, carotic blood flow and cardiac out put.

      GLP-2 will be administered subcutaneously, and the effect monitored by doppler ultra sound
      scannings and cotinuesly measuring of cardiac out put and blood pressure.

      The study will include 15 healhty volunteers, 10 wil receive 450 nmol GLP-2 and 5 will
      receive 1 ml of isotonic saline (as baseline reference).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      se the above
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>effect of glp-2</measure>
    <time_frame>during study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>potential new ideas for further studies</measure>
    <time_frame>months to years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Regional Blood Flow</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>450 nmol GLP-2 SC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 ml isotonic saline SC</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucagonlike peptide</intervention_name>
    <description>450 nmol native form, synthetic</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 20-60

          -  Healthy

          -  No medication

          -  Not pregnant

        Exclusion Criteria:

          -  All of the persons not meeting the abowe mentioned criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>lasse bremholm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup university hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glostrup University Hospital</name>
      <address>
        <city>Glostrup</city>
        <state>Region Hovedstaden</state>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2007</study_first_submitted>
  <study_first_submitted_qc>October 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2007</study_first_posted>
  <last_update_submitted>February 10, 2011</last_update_submitted>
  <last_update_submitted_qc>February 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 11, 2011</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

